Trabectedin First Line Therapy In Unfit Sarcoma Study

NCT02066675 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive
Standard Chemotherapy

Interventions

DRUG: Trabectedin

Sponsor

Italian Sarcoma Group